GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » EV-to-Revenue

Philogen SpA (STU:78Q) EV-to-Revenue : 13.09 (As of Jun. 24, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Philogen SpA's enterprise value is €968.81 Mil. Philogen SpA's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €74.00 Mil. Therefore, Philogen SpA's EV-to-Revenue for today is 13.09.

The historical rank and industry rank for Philogen SpA's EV-to-Revenue or its related term are showing as below:

STU:78Q' s EV-to-Revenue Range Over the Past 10 Years
Min: 8.15   Med: 32.59   Max: 202.75
Current: 13.1

During the past 5 years, the highest EV-to-Revenue of Philogen SpA was 202.75. The lowest was 8.15. And the median was 32.59.

STU:78Q's EV-to-Revenue is ranked worse than
62.51% of 995 companies
in the Biotechnology industry
Industry Median: 7.6 vs STU:78Q: 13.10

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-24), Philogen SpA's stock price is €25.80. Philogen SpA's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €1.84. Therefore, Philogen SpA's PS Ratio for today is 14.05.


Philogen SpA EV-to-Revenue Historical Data

The historical data trend for Philogen SpA's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA EV-to-Revenue Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
- 197.11 20.83 29.49 9.25

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.83 - 29.49 - 9.25

Competitive Comparison of Philogen SpA's EV-to-Revenue

For the Biotechnology subindustry, Philogen SpA's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Philogen SpA's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Philogen SpA's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Philogen SpA's EV-to-Revenue falls into.


;
;

Philogen SpA EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Philogen SpA's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=968.806/73.996
=13.09

Philogen SpA's current Enterprise Value is €968.81 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Philogen SpA's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €74.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Philogen SpA  (STU:78Q) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Philogen SpA's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=25.80/1.836
=14.05

Philogen SpA's share price for today is €25.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was €1.84.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Philogen SpA EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Philogen SpA's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Philogen SpA Business Description

Traded in Other Exchanges
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines